PATENT CLAIM ANALYSIS

Application Number: 15748014
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "387000"]

Abstract:
The present invention relates to the adduct (2E)-but-2-enedioic acid-3-(2-{[4-(trifluoromethoxy)phenyl]amino}-1-[(1R,5R)-3,3,5-trimethylcyclohexyl]-1H-benzimidazol-yl)propanoic acid (1:4), methods for preparing this adduct, pharmaceutical compositions comprising this adduct and also the use of this adduct for preparing a medicament for the treatment of a disease.

Claim (Index 3):
The adduct according to  claim 1  in crystalline form, characterized by maxima in the Raman spectrum at the following wavenumbers in units of cm \u22121 : 3088, 3047, 2934, 2910, 2874, 2771, 2717, 1658, 1632, 1615, 1521, 1463, 1451, 1420, 1338, 1306, 1294, 1277, 1245, 1198, 1184, 1167, 1155, 1127, 1109, 1077, 1049, 1018, 979, 961, 943, 922, 908, 877, 866, 839, 817, 789, 767, 714, 700, 685, 646, 631, 613, 568, 517, 503, 450, 438, 416, 388, 358, 339, 330, and 102.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.51111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15118154', '15744641', '15520385', '15742363', '15520384']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7601356044025384
- 35 USC 102 Novelty (BERT): 0.5282357696008039
- Combined Prediction Score: 0.7369456209223648
- Mean Citation Score: 285.973766
- Max Citation Score: 307.88104
- Similarity Product: 203.765223144846

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test